176 related articles for article (PubMed ID: 35554644)
1. Value of native T1 mapping in the prediction of major adverse cardiovascular events in hemodialysis patients.
Qin L; Gu S; Xiao R; Liu P; Yan F; Yu H; Yang W
Eur Radiol; 2022 Oct; 32(10):6878-6890. PubMed ID: 35554644
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
[TBL] [Abstract][Full Text] [Related]
3. The association of secondary hyperparathyroidism and myocardial damages in hemodialysis end-stage renal disease patients: assessed by cardiovascular magnetic resonance native T1 mapping.
Xu H; Peng W; Yang Z; Zhang Y; Xia C; Li Z; Xu R; Guo Y
J Cardiovasc Magn Reson; 2021 Mar; 23(1):23. PubMed ID: 33691727
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the Prognostic Value of MRI Left Ventricular Global Function Index (LVGFI) in Patients With End-Stage Renal Disease Under Maintenance Dialysis.
Zhang TY; An DA; Fang Y; Zhou H; Yan H; Chen B; Lu R; Fang W; Wang Q; Che X; Xu Y; Huang J; Jin H; Shen J; Mou S; Wu LM
J Magn Reson Imaging; 2024 Jun; 59(6):2275-2286. PubMed ID: 37668069
[TBL] [Abstract][Full Text] [Related]
5. Left Ventricular Vertical Run-Length Nonuniformity MRI Adds Prognostic Value to MACE in Patients with End-Stage Renal Disease.
Zhang TY; An DA; Zhou H; Chen B; Lu R; Fang W; Wang Q; Huang J; Jin H; Shen J; Zhou Y; Hu J; Bautista M; Ouchi T; Wu LM; Mou S
J Magn Reson Imaging; 2024 Feb; 59(2):522-532. PubMed ID: 37203257
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Remote Myocardium Alterations Assessed by Quantitative Noncontrast T1 Mapping in ST-Segment Elevation Myocardial Infarction.
Reinstadler SJ; Stiermaier T; Liebetrau J; Fuernau G; Eitel C; de Waha S; Desch S; Reil JC; Pöss J; Metzler B; Lücke C; Gutberlet M; Schuler G; Thiele H; Eitel I
JACC Cardiovasc Imaging; 2018 Mar; 11(3):411-419. PubMed ID: 28624398
[TBL] [Abstract][Full Text] [Related]
7. Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients.
Graham-Brown MP; Rutherford E; Levelt E; March DS; Churchward DR; Stensel DJ; McComb C; Mangion K; Cockburn S; Berry C; Moon JC; Mark PB; Burton JO; McCann GP
J Cardiovasc Magn Reson; 2017 Feb; 19(1):21. PubMed ID: 28238284
[TBL] [Abstract][Full Text] [Related]
8. Incremental Values of T1 Mapping in the Prediction of Sudden Cardiac Death Risk in Hypertrophic Cardiomyopathy: A Comparison With Two Guidelines.
Qin L; Min J; Chen C; Zhu L; Gu S; Zhou M; Yang W; Yan F
Front Cardiovasc Med; 2021; 8():661673. PubMed ID: 34169099
[No Abstract] [Full Text] [Related]
9. Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy.
Vita T; Gräni C; Abbasi SA; Neilan TG; Rowin E; Kaneko K; Coelho-Filho O; Watanabe E; Mongeon FP; Farhad H; Rassi CH; Choi YL; Cheng K; Givertz MM; Blankstein R; Steigner M; Aghayev A; Jerosch-Herold M; Kwong RY
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1659-1669. PubMed ID: 30448130
[TBL] [Abstract][Full Text] [Related]
10. Novel cardiac nuclear magnetic resonance method for noninvasive assessment of myocardial fibrosis in hemodialysis patients.
Graham-Brown MP; March DS; Churchward DR; Stensel DJ; Singh A; Arnold R; Burton JO; McCann GP
Kidney Int; 2016 Oct; 90(4):835-44. PubMed ID: 27633869
[TBL] [Abstract][Full Text] [Related]
11. Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.
Rutherford E; Talle MA; Mangion K; Bell E; Rauhalammi SM; Roditi G; McComb C; Radjenovic A; Welsh P; Woodward R; Struthers AD; Jardine AG; Patel RK; Berry C; Mark PB
Kidney Int; 2016 Oct; 90(4):845-52. PubMed ID: 27503805
[TBL] [Abstract][Full Text] [Related]
12. Noncontrast Myocardial T1 Mapping by Cardiac Magnetic Resonance Predicts Outcome in Patients With Aortic Stenosis.
Lee H; Park JB; Yoon YE; Park EA; Kim HK; Lee W; Kim YJ; Cho GY; Sohn DW; Greiser A; Lee SP
JACC Cardiovasc Imaging; 2018 Jul; 11(7):974-983. PubMed ID: 29153562
[TBL] [Abstract][Full Text] [Related]
13. Global Coronary Flow Reserve Measured During Stress Cardiac Magnetic Resonance Imaging Is an Independent Predictor of Adverse Cardiovascular Events.
Indorkar R; Kwong RY; Romano S; White BE; Chia RC; Trybula M; Evans K; Shenoy C; Farzaneh-Far A
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1686-1695. PubMed ID: 30409558
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of non-infarcted myocardium correlated with microvascular impairment evaluated dynamically by native T1 mapping.
Chen BH; An DA; Wu CW; Yue T; Bautista M; Ouchi E; Xu JR; Hu J; Zhou Y; Pu J; Wu LM
Insights Imaging; 2023 Mar; 14(1):50. PubMed ID: 36941401
[TBL] [Abstract][Full Text] [Related]
15. Myocardial changes on 3T cardiovascular magnetic resonance imaging in response to haemodialysis with fluid removal.
Rankin AJ; Mangion K; Lees JS; Rutherford E; Gillis KA; Edy E; Dymock L; Treibel TA; Radjenovic A; Patel RK; Berry C; Roditi G; Mark PB
J Cardiovasc Magn Reson; 2021 Nov; 23(1):125. PubMed ID: 34758850
[TBL] [Abstract][Full Text] [Related]
16. Associations of B-type natriuretic peptide (BNP) and dialysis vintage with CMRI-derived cardiac indices in stable hemodialysis patients with a preserved left ventricular ejection fraction.
Han X; He F; Cao Y; Li Y; Gu J; Shi H
Int J Cardiovasc Imaging; 2020 Nov; 36(11):2265-2278. PubMed ID: 32686028
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy.
Li Y; Liu X; Yang F; Wang J; Xu Y; Fang T; Pu L; Zhou X; Han Y; Chen Y
Eur Radiol; 2021 Jul; 31(7):4557-4567. PubMed ID: 33449190
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of left ventricular global function index in patients after ST-segment elevation myocardial infarction.
Reinstadler SJ; Klug G; Feistritzer HJ; Kofler M; Pernter B; Göbel G; Henninger B; Müller S; Franz WM; Metzler B
Eur Heart J Cardiovasc Imaging; 2016 Feb; 17(2):169-76. PubMed ID: 26056134
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Strain by Tissue Tracking Cardiac Magnetic Resonance After ST-Segment Elevation Myocardial Infarction.
Gavara J; Rodriguez-Palomares JF; Valente F; Monmeneu JV; Lopez-Lereu MP; Bonanad C; Ferreira-Gonzalez I; Garcia Del Blanco B; Rodriguez-Garcia J; Mutuberria M; de Dios E; Rios-Navarro C; Perez-Sole N; Racugno P; Paya A; Minana G; Canoves J; Pellicer M; Lopez-Fornas FJ; Barrabes J; Evangelista A; Nunez J; Chorro FJ; Garcia-Dorado D; Bodi V
JACC Cardiovasc Imaging; 2018 Oct; 11(10):1448-1457. PubMed ID: 29248649
[TBL] [Abstract][Full Text] [Related]
20. Safety and Prognostic Value of Vasodilator Stress Cardiovascular Magnetic Resonance in Patients With Heart Failure and Reduced Ejection Fraction.
Pezel T; Sanguineti F; Kinnel M; Landon V; Bonnet G; Garot P; Hovasse T; Unterseeh T; Champagne S; Louvard Y; Claude Morice M; Garot J
Circ Cardiovasc Imaging; 2020 Sep; 13(9):e010599. PubMed ID: 32873071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
